Peter Pekos
Director/Board Member presso CARDIOL THERAPEUTICS INC.
Patrimonio netto: 845 795 $ in data 31/03/2024
Profilo
Peter Pekos is the founder of Dalton Chemical Laboratories, Inc. where he holds the title of President & Chief Executive Officer since 1986.
He is also the founder of Ashbury Biologicals, Inc., Jupiter Consumer Products Ltd.
Mr. Pekos's current jobs include being an Independent Director at Cardiol Therapeutics, Inc., a Director at Diamond Therapeutics, Inc., and a Member-Editorial Board at Biotechnology Focus.
Mr. Pekos's former job was as Chairman at ventureLAB from 2011 to 2020.
Mr. Pekos received his undergraduate degree from the University of Toronto in 1983 and his graduate degree from York University in 1986.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
29/02/2024 | 467 290 ( 0.72% ) | 845 795 $ | 31/03/2024 |
Posizioni attive di Peter Pekos
Società | Posizione | Inizio |
---|---|---|
CARDIOL THERAPEUTICS INC. | Director/Board Member | 15/12/2017 |
Dalton Chemical Laboratories, Inc.
Dalton Chemical Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Dalton Chemical Laboratories, Inc. engages in the provision of integrated drug discovery, development and manufacturing services. Its products include building blocks, glitazones, labelled compounds, natural compounds, peptides, steroids and controlled drugs. The firm also offers formulation development, flow chemistry, conjugation and contract research services. The company was founded by Peter Pekos in 1986 and is headquartered in Toronto, Canada. | Chief Executive Officer | 01/01/1986 |
Biotechnology Focus | Corporate Officer/Principal | - |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | Director/Board Member | - |
Precedenti posizioni note di Peter Pekos
Società | Posizione | Fine |
---|---|---|
Venturelab
Venturelab Miscellaneous Commercial ServicesCommercial Services ventureLAB provides business development solutions. Its programs focuses on capital, talent, technology, and customers. The company is headquartered in Markham, Canada. | Chairman | 01/01/2020 |
Jupiter Consumer Products Ltd. | Founder | - |
Ashbury Biologicals, Inc. | Founder | - |
Formazione di Peter Pekos
York University | Graduate Degree |
University of Toronto | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CARDIOL THERAPEUTICS INC. | Health Technology |
Aziende private | 6 |
---|---|
Dalton Chemical Laboratories, Inc.
Dalton Chemical Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Dalton Chemical Laboratories, Inc. engages in the provision of integrated drug discovery, development and manufacturing services. Its products include building blocks, glitazones, labelled compounds, natural compounds, peptides, steroids and controlled drugs. The firm also offers formulation development, flow chemistry, conjugation and contract research services. The company was founded by Peter Pekos in 1986 and is headquartered in Toronto, Canada. | Process Industries |
Ashbury Biologicals, Inc. | |
Jupiter Consumer Products Ltd. | |
Biotechnology Focus | |
Venturelab
Venturelab Miscellaneous Commercial ServicesCommercial Services ventureLAB provides business development solutions. Its programs focuses on capital, talent, technology, and customers. The company is headquartered in Markham, Canada. | Commercial Services |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | Health Technology |
- Borsa valori
- Insiders
- Peter Pekos